NCT01875237 2019-07-16Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide GeneM.D. Anderson Cancer CenterPhase 1/2 Terminated3 enrolled 15 charts
NCT01177371 2010-08-09High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaCase Comprehensive Cancer CenterPhase 2 Completed13 enrolled